SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 8.35 |
Enterprise Value ($M) | -13.19 |
Book Value ($M) | 20.62 |
Book Value / Share | 3.75 |
Price / Book | 0.40 |
NCAV ($M) | 20.22 |
NCAV / Share | 3.68 |
Price / NCAV | 0.41 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.63 |
Return on Assets (ROA) | -0.39 |
Return on Equity (ROE) | -0.43 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 7.01 |
Current Ratio | 7.01 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 23.58 |
Assets | 23.98 |
Liabilities | 3.36 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 1.50 |
Operating Income | -14.32 |
Net Income | -12.96 |
Earnings Per Share Basic And Diluted | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.56 |
Cash from Investing | -0.02 |
Cash from Financing | 14.82 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Sio Capital Management, LLC | 5.04 | -1.21 | |
13G/A | Stonepine Capital Management, LLC | 5.10 | -21.63 | |
13G | Nantahala Capital Management, LLC | 7.30 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,404 | 11,375 | 12.34 | |
1,981 | 8,405 | 23.57 | |
1,294 | 11,950 | 10.83 | |
(click for more detail) |
Similar Companies | |
---|---|
ANEB – Anebulo Pharmaceuticals, Inc. | ANIX – Anixa Biosciences, Inc. |
APM – Aptorum Group Limited | APVO – Aptevo Therapeutics Inc. |
ARTL – Artelo Biosciences, Inc. |
Financial data and stock pages provided by
Fintel.io